Kezar Life Sciences IncNASDAQ:KZRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6566
- TODAY'S CHANGE (%)0.0003 (0.0457%)
- Bid / Lots0.6565/ 1
- Ask / Lots0.6575/ 4
- Open / Previous Close0.6509 / 0.6563
- Day Range
- 52 Week Range
- Volume213,634
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KZR |
|---|---|---|
| 09:32 ET | 1403 | 0.6509 |
| 09:45 ET | 100 | 0.6555 |
| 09:48 ET | 100 | 0.6528 |
| 09:50 ET | 100 | 0.6528 |
| 09:52 ET | 795 | 0.6528 |
| 10:01 ET | 100 | 0.6528 |
| 10:08 ET | 100 | 0.6555 |
| 10:10 ET | 11008 | 0.6562 |
| 10:12 ET | 200 | 0.6598 |
| 10:14 ET | 861 | 0.6595 |
| 10:15 ET | 100 | 0.6595 |
| 10:17 ET | 200 | 0.65495 |
| 10:19 ET | 908 | 0.6595 |
| 10:24 ET | 100 | 0.6549 |
| 10:26 ET | 200 | 0.6549 |
| 10:39 ET | 100 | 0.6541 |
| 10:44 ET | 100 | 0.65405 |
| 10:50 ET | 300 | 0.6541 |
| 10:53 ET | 355 | 0.65405 |
| 10:57 ET | 11267 | 0.6507 |
| 11:00 ET | 300 | 0.6474 |
| 11:02 ET | 11950 | 0.6493 |
| 11:06 ET | 100 | 0.6473 |
| 11:09 ET | 1820 | 0.6464 |
| 11:11 ET | 720 | 0.64645 |
| 11:13 ET | 1300 | 0.64645 |
| 11:15 ET | 500 | 0.6453 |
| 11:18 ET | 400 | 0.6475 |
| 11:20 ET | 259 | 0.6464 |
| 11:22 ET | 1400 | 0.6475 |
| 11:24 ET | 1193 | 0.6465 |
| 11:26 ET | 100 | 0.6476 |
| 11:27 ET | 100 | 0.6465 |
| 11:33 ET | 3778 | 0.65045 |
| 11:36 ET | 100 | 0.6554 |
| 11:38 ET | 300 | 0.6554 |
| 11:40 ET | 1000 | 0.65045 |
| 11:42 ET | 400 | 0.6554 |
| 11:44 ET | 300 | 0.6502 |
| 11:45 ET | 397 | 0.6502 |
| 11:49 ET | 100 | 0.6549 |
| 11:51 ET | 200 | 0.6502 |
| 11:54 ET | 200 | 0.6502 |
| 11:56 ET | 754 | 0.6502 |
| 11:58 ET | 1109 | 0.64895 |
| 12:00 ET | 948 | 0.6494 |
| 12:02 ET | 5180 | 0.64925 |
| 12:03 ET | 300 | 0.64925 |
| 12:05 ET | 200 | 0.6489 |
| 12:07 ET | 1890 | 0.6499 |
| 12:09 ET | 1600 | 0.65 |
| 12:12 ET | 9306 | 0.6524 |
| 12:14 ET | 3462 | 0.6535 |
| 12:16 ET | 200 | 0.6535 |
| 12:18 ET | 200 | 0.6594 |
| 12:20 ET | 1400 | 0.658 |
| 12:21 ET | 500 | 0.6529 |
| 12:23 ET | 300 | 0.6529 |
| 12:25 ET | 100 | 0.658 |
| 12:27 ET | 824 | 0.6507 |
| 12:30 ET | 3286 | 0.6507 |
| 12:32 ET | 300 | 0.64945 |
| 12:34 ET | 400 | 0.6495 |
| 12:36 ET | 948 | 0.6524 |
| 12:38 ET | 1565 | 0.6537 |
| 12:41 ET | 11222 | 0.66 |
| 12:43 ET | 1600 | 0.66 |
| 12:45 ET | 100 | 0.66 |
| 12:48 ET | 200 | 0.65525 |
| 12:50 ET | 850 | 0.6595 |
| 12:52 ET | 617 | 0.6595 |
| 12:54 ET | 100 | 0.6595 |
| 12:56 ET | 500 | 0.655 |
| 12:59 ET | 100 | 0.6595 |
| 01:01 ET | 1000 | 0.6594 |
| 01:10 ET | 2350 | 0.6529 |
| 01:12 ET | 6321 | 0.6524 |
| 01:14 ET | 800 | 0.6517 |
| 01:15 ET | 100 | 0.6509 |
| 01:17 ET | 1000 | 0.6524 |
| 01:19 ET | 300 | 0.65155 |
| 01:21 ET | 1400 | 0.6522 |
| 01:24 ET | 1691 | 0.64825 |
| 01:26 ET | 1902 | 0.6469 |
| 01:28 ET | 695 | 0.6476 |
| 01:30 ET | 300 | 0.6468 |
| 01:32 ET | 200 | 0.6466 |
| 01:35 ET | 2535 | 0.6423 |
| 01:37 ET | 300 | 0.6432 |
| 01:39 ET | 1313 | 0.6411 |
| 01:42 ET | 457 | 0.6414 |
| 01:44 ET | 527 | 0.6411 |
| 01:46 ET | 51745 | 0.6599 |
| 01:48 ET | 800 | 0.6563 |
| 01:50 ET | 1670 | 0.6561 |
| 01:51 ET | 290 | 0.6595 |
| 01:53 ET | 500 | 0.6562 |
| 01:55 ET | 300 | 0.6595 |
| 01:57 ET | 200 | 0.6595 |
| 02:00 ET | 1105 | 0.65615 |
| 02:02 ET | 300 | 0.65615 |
| 02:04 ET | 1460 | 0.6561 |
| 02:06 ET | 700 | 0.6561 |
| 02:08 ET | 1200 | 0.6584 |
| 02:09 ET | 300 | 0.6583 |
| 02:11 ET | 3326 | 0.6575 |
| 02:13 ET | 400 | 0.6575 |
| 02:15 ET | 300 | 0.6575 |
| 02:18 ET | 312 | 0.657 |
| 02:20 ET | 100 | 0.6569 |
| 02:22 ET | 362 | 0.6566 |
Jun 7, 2024
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4), from 5:59PM ET on Friday Jun 07, 2024 by Dow Jones
5:59PM ET on Friday Jun 07, 2024 by Dow Jones
May 29, 2024
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference, from 4:01PM ET on Wednesday May 29, 2024 by Dow Jones
4:01PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kezar Life Sciences Inc | 47.8M | -0.5x | --- |
LAVA Therapeutics NV | 51.0M | -1.8x | --- |
Kronos Bio Inc | 56.8M | -0.5x | --- |
DURECT Corp | 43.8M | -1.5x | --- |
BioLine RX Ltd | 52.8M | -0.7x | --- |
Atara Biotherapeutics Inc | 38.2M | -0.1x | --- |
Company Information
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). Its oncology product candidate, KZR-261, is a small molecule agent, targeting the Sec61 translocon and protein secretion pathway, being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. This study is being conducted in two parts: dose escalation in patients with locally advanced or metastatic solid malignancies, and dose expansion in patients with selected tumor types.
Contact Information
- Headquarters
- 4000 Shoreline Ct Ste 300SOUTH SAN FRANCISCO, CA, United States 94080-2005
- Phone
- 650-822-5600
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Graham Cooper
- Director
- Christopher Kirk
- Chief Financial Officer, Secretary
- Marc Belsky
- Chief Business Officer
- Nick Mordwinkin
- Chief Legal Officer
- Mark Schiller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $47.8M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 72.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.28 |
EPS | $-1.40 |
Book Value | $2.58 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 6.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,591.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
